Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.01 (-1.00%)
Close on Nov 13, 2026Market cap $18.88MP/E –Yield –
Cocrystal Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cocrystal Pharma's enterprise value was $11.90M on Nov 11, 2026, against $6.09M a year earlier. Over the last 5 years it ranged from -$54.88M to $13.83M, with a median of -$135.02K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $11.90M | +136.1% |
| 2025 | Dec 31, 2025 | $5.04M | -33.1% |
| 2024 | Dec 31, 2024 | $7.53M | – |
| 2023 | Dec 29, 2023 | -$12.22M | – |
| 2022 | Dec 30, 2022 | -$40.73M | -2477.7% |
| 2021 | Dec 31, 2021 | $1.71M | -97.2% |
| 2020 | Dec 31, 2020 | $61.47M | +535.4% |
| 2019 | Dec 31, 2019 | $9.67M | -90.6% |
| 2018 | Dec 31, 2018 | $103.04M | -28.6% |
| 2017 | Dec 29, 2017 | $144.32M | -47.1% |
| 2016 | Dec 30, 2016 | $272.57M | -55.0% |
| 2015 | Dec 31, 2015 | $605.58M | – |
| 2014 | Dec 31, 2014 | -$5.45M | -100.1% |
| 2013 | Dec 31, 2013 | $4.44B | -78.3% |
| 2012 | Dec 31, 2012 | $20.52B | – |
See a number that looks wrong?